In March 2025, the company announced new options for a immediate-to-consumer featuring of its Wegovy weight loss drug. The company founded a brand new pharmacy, called NovoCare, which might demand customers $499 a month for entry to the drug, lower than fifty percent the cost of the drug by means of other pharmaceutical distribution networks.[53]to